Eli Kraus Ph.D. has been in the biotechnology field for more than 25 years with experience in process development, clinical and commercial GMP manufacturing, technology transfer and CMC. Prior to Landmark Bio Dr. Kraus had an extensive career at Amgen in Process Development, supporting programs from clinical development through commercialization. At Landmark Bio, Dr. Kraus is focused on bringing GMP innovation, for our clients as they progress from bench to clinic.
Dr. Kraus received his Ph.D. in Cancer Biology at the University of Texas M.D. Anderson Cancer Center where he studied the oncogene P53 and a BS in Biology from Syracuse University.